- Home
- BROS vs CORT Comparison
BROS vs CORT Comparison
Compare BROS & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BROS
- CORT
- Stock Information
- Founded
- BROS 1992
- CORT 1998
- Country
- BROS United States
- CORT United States
- Employees
- BROS N/A
- CORT N/A
- Industry
- BROS Restaurants
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- BROS Consumer Discretionary
- CORT Health Care
- Exchange
- BROS Nasdaq
- CORT Nasdaq
- Market Cap
- BROS 7.6B
- CORT 7.1B
- IPO Year
- BROS 2021
- CORT N/A
- Fundamental
- Price
- BROS $64.90
- CORT $75.80
- Analyst Decision
- BROS Strong Buy
- CORT Strong Buy
- Analyst Count
- BROS 15
- CORT 4
- Target Price
- BROS $78.27
- CORT $142.00
- AVG Volume (30 Days)
- BROS 3.3M
- CORT 1.2M
- Earning Date
- BROS 05-07-2025
- CORT 05-05-2025
- Dividend Yield
- BROS N/A
- CORT N/A
- EPS Growth
- BROS 109.32
- CORT 8.36
- EPS
- BROS 0.38
- CORT 1.14
- Revenue
- BROS $1,361,068,000.00
- CORT $685,446,000.00
- Revenue This Year
- BROS $26.31
- CORT $35.85
- Revenue Next Year
- BROS $23.86
- CORT $35.22
- P/E Ratio
- BROS $168.86
- CORT $66.36
- Revenue Growth
- BROS 30.42
- CORT 30.93
- 52 Week Low
- BROS $26.96
- CORT $27.30
- 52 Week High
- BROS $86.88
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- BROS 49.83
- CORT 58.35
- Support Level
- BROS $58.20
- CORT $68.86
- Resistance Level
- BROS $73.93
- CORT $75.50
- Average True Range (ATR)
- BROS 2.71
- CORT 3.09
- MACD
- BROS 0.36
- CORT 0.36
- Stochastic Oscillator
- BROS 42.59
- CORT 88.00
About BROS Dutch Bros Inc.
Dutch Bros Inc is an operator and franchisor of drive-thru coffee shops that are focused on serving hand-crafted beverages. The company's hand-crafted beverage-focused lineup features hot and cold espresso-based beverages, cold brew coffee products, proprietary energy drinks, tea, lemonade, smoothies and other beverages. The company has two reportable operating segments Company-operated shops and Franchising. It derives maximum revenue from Company operated shops.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.